Testing a glowing dye to help surgeons see brain growths
Original title: Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a dye meant to make brain growths glow during surgery.
Who this trial is for. This study is for people having surgery to remove a growth inside the brain. It tests a dye called panitumumab-IRDye800, also called pan800, that is made to stick to a protein called EGFR and glow.
Where it stands. This is a pilot study. It is looking at how safe the dye is and how well it shows growths during surgery. The trial has not reported results yet.
What this means, and what it doesn't
What it could mean: The dye is meant to help surgeons see better. It is not a treatment for the growth itself. Someone facing brain surgery could ask their care team about this study.
What it doesn't mean: This does not mean the dye is proven. A trial is a test, not care your doctor can give you today. Joining a trial is not a promise that it will help. It is not a cure.
Source: ClinicalTrials.gov, October 16, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.